i

iNtRON Biotechnology Inc
KOSDAQ:048530

Watchlist Manager
iNtRON Biotechnology Inc
KOSDAQ:048530
Watchlist
Price: 3 055 KRW 4.8% Market Closed
Market Cap: 104.3B KRW

Operating Margin

-129.6%
Current
Declining
by 64.3%
vs 3-y average of -65.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-129.6%
=
Operating Income
₩-7.2B
/
Revenue
₩5.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-129.6%
=
Operating Income
₩-7.2B
/
Revenue
₩5.6B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
iNtRON Biotechnology Inc
KOSDAQ:048530
96.6B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
378B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
176.8B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.6B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.4B USD
Loading...
AU
CSL Ltd
ASX:CSL
85.6B AUD
Loading...
NL
argenx SE
XBRU:ARGX
41.5B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
No Stocks Found

Market Distribution

Lower than 95% of companies in Korea
Percentile
5th
Based on 2 615 companies
5th percentile
-129.6%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

iNtRON Biotechnology Inc
Glance View

Market Cap
104.3B KRW
Industry
Biotechnology

iNtRON Biotechnology, Inc. is a Korea-based company principally engaged in the biotechnology industry. The Company operates its business through two main divisions: genetic reagent division and molecular diagnostics division. Its genetic reagent division is involved in the research and development of reagents, which are under the brand names of Maxime and pLUG for life science research. Its molecular diagnostics division is engaged in the development and production of nucleic acid tester for infectious diseases. It also engages in the operation of veterinary antibiotic alternative business and new biopharmaceuticals development business. The Company distributes its products within domestic market and to overseas markets.

iNtRON Biotechnology Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-129.6%
=
Operating Income
₩-7.2B
/
Revenue
₩5.6B
What is iNtRON Biotechnology Inc's current Operating Margin?

The current Operating Margin for iNtRON Biotechnology Inc is -129.6%, which is below its 3-year median of -65.3%.

How has Operating Margin changed over time?

Over the last 3 years, iNtRON Biotechnology Inc’s Operating Margin has decreased from 18.6% to -129.6%. During this period, it reached a low of -131.6% on Jun 30, 2025 and a high of 18.6% on Aug 30, 2022.

Back to Top